Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.80 HKD
Change Today +0.07 / 1.88%
Volume 1.7M
853 On Other Exchanges
Hong Kong
As of 4:01 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

microport scientific corp (853) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/25/14 - $5.98
52 Week Low
01/19/15 - $3.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MICROPORT SCIENTIFIC CORP (853)

Related News

No related news articles were found.

microport scientific corp (853) Related Businessweek News

No Related Businessweek News Found

microport scientific corp (853) Details

MicroPort Scientific Corporation, a medical technology company, through its subsidiaries, develops, manufactures, and sells interventional medical devices in the People’s Republic of China. It operates through seven segments: Cardiovascular Devices, Endovascular Devices, Neurovascular Devices, Electrophysiology Devices, Orthopedic Devices, Diabetes Care and Endocrinal Management, and Surgical Management. The Cardiovascular Devices segment develops, manufactures, and sells coronary stents and related delivery systems, as well as balloon catheters and accessories. The Endovascular Devices segment offers products and therapies to treat abdominal and thoracic aortic aneurysms and peripheral vascular disease. This segment’s endovascular devices include AAA/TAA stent graft systems; Hercules balloon dilation catheters; surgical stent graft systems; and peripheral stent systems. The Neurovascular Devices segment develops, manufactures, and markets medical devices for treating the central nervous system related vascular diseases. This segment’s products include WILLIS, an intracranial stent graft system. The Electrophysiology Devices segment develops, manufactures, and markets minimally invasive medical devices for the treatment of electrophysiological diseases. The Orthopedics Devices segment develops, manufactures, and markets instruments and implants for treating orthopedic conditions. The Diabetes Care and Endocrinal Management segment develops, manufactures, monitors, and manages medical devices for the treatment of diabetes and endocrinal. The Surgical Management segment specializes in extracorporeal circulation and cardiovascular-related devices. This segment’s products consist of membrane oxygenation system, Amender PDA Occluder, and Amender ASD Occluder. The company has operations primarily in the People’s Republic of China, rest of Asia, South America, and Europe. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, China.

2,914 Employees
Last Reported Date: 09/18/14
Founded in 1998

microport scientific corp (853) Top Compensated Officers

Founder, Chairman of the Board, Chief Executi...
Total Annual Compensation: CNY4.1M
Compensation as of Fiscal Year 2013.

microport scientific corp (853) Key Developments

MicroPort Scientific Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 11:30 AM

MicroPort Scientific Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 11:30 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Hongbin Sun, Chief Financial Officer and Member of Executive Committee.

MicroPort Scientific Corporation Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2014

MicroPort Scientific Corporation reported unaudited consolidated earnings results for the six months ended June 30, 2014. For the six months, the company reported turnover of USD 183.80 million compared to USD 67.68 million a year ago. Profit from operations was USD 681,000 compared to USD 18,742,000 a year ago. Loss before tax was USD 4.39 million compared to profit before tax of USD 18.49 million a year ago. Loss for the period was USD 9.94 million or 0.75 cents per diluted share compared to profit for the year of USD 14.77 million or 1.03 cents per diluted share a year ago. EBITDA was USD 19.2 million compared to USD 21.7 million a year ago. The decrease in net profit was primarily due to the consolidation of the newly acquired OrthoRecon business which incurred a net loss of USD 26.5 million. The increase in EBITDA was primarily due to revenue growth and increase of government grant.

MicroPort Scientific Corporation to Report First Half, 2014 Results on Aug 27, 2014

MicroPort Scientific Corporation announced that they will report first half, 2014 results on Aug 27, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
853:HK $3.80 HKD +0.07

853 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 853.
View Industry Companies

Industry Analysis


Industry Average

Valuation 853 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.7x
Price/Book 10.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 13.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MICROPORT SCIENTIFIC CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at